Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Biotech
Whitehawk swoops in for five ADCs via deal with Biocytogen
Biocytogen and Whitehawk Therapeutics are joining forces to develop bispecific antibody-drug conjugates with Biocytogen's discovery platform.
Will Maddox
Jul 7, 2026 10:40am
Boehringer bags viral vector platform for cancer vaccine R&D
Jul 7, 2026 10:35am
Kailera’s oral GLP-1 asset hits goals in Chinese phase 3 trials
Jul 7, 2026 8:44am
Fierce Pharma
Vertex to pay $10B for Crinetics in its largest-ever deal
Jul 7, 2026 8:08am
Genentech sees 103 layoffs, pens $490M breast cancer collab
Jul 6, 2026 7:30am
Novartis to pay $1.1B upfront for Myricx to expand ADC pipeline
Jul 6, 2026 5:10am
